Joyce S. Lee, MD
Associate Professor, Medicine
Pulmonary Sciences and Critical Care
University of Colorado Denver
Anschutz Medical Campus
Upon completion of this activity, participants should be able to:
- Differentiate idiopathic pulmonary fibrosis (IPF) from other common ILDs, such as connective tissue disease-associated ILD (CTD-ILD), accurately and efficiently using recommended clinical evaluation, radiologic testing, and pathologic testing as needed
- Apply evidence informing the use of antifibrotic therapy, nonpharmacologic strategies, and management of risk factors and comorbidities in patients with IPF to formulate treatment plans
- Individualize treatment of IPF based on patient characteristics and preferences, using shared decision-making
This activity is provided by Paradigm Medical Communications, LLC.
Held in collaboration with the Pulmonary Fibrosis Foundation.